Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.

[1]  M. Khoury,et al.  A public health perspective on a national precision medicine cohort: balancing long-term knowledge generation with early health benefit. , 2015, JAMA.

[2]  Damian Smedley,et al.  Construction and accessibility of a cross-species phenotype ontology along with gene annotations for biomedical research , 2013, F1000Research.

[3]  Euan A Ashley,et al.  Clinical interpretation and implications of whole-genome sequencing. , 2014, JAMA.

[4]  C. Austin,et al.  The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact , 2017, European Journal of Human Genetics.

[5]  S. Mundlos,et al.  The Human Phenotype Ontology , 2010, Clinical genetics.

[6]  W. Riley,et al.  Precision Public Health for the Era of Precision Medicine. , 2016, American journal of preventive medicine.

[7]  Orion J. Buske,et al.  The Matchmaker Exchange: A Platform for Rare Disease Gene Discovery , 2015, Human mutation.

[8]  Simon Woods,et al.  The risk of re-identification versus the need to identify individuals in rare disease research , 2016, European Journal of Human Genetics.

[9]  Timo Lassmann,et al.  The rare and undiagnosed diseases diagnostic service – application of massively parallel sequencing in a state-wide clinical service , 2016, Orphanet Journal of Rare Diseases.

[10]  F. Stanley,et al.  Case for mandatory fortification of food with folate in Australia, for the prevention of neural tube defects. , 2004, Birth defects research. Part A, Clinical and molecular teratology.

[11]  James F. Thrasher,et al.  The Integration of Genomics into Public Health Research, Policy and Practice in the United States , 2001, Public Health Genomics.

[12]  S. Zubrick,et al.  The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort , 2016, Genetics in Medicine.

[13]  F. Dhombres,et al.  Representation of rare diseases in health information systems: The orphanet approach to serve a wide range of end users , 2012, Human mutation.

[14]  J. Goldblatt,et al.  The Impact of Single Gene and Chromosomal Disorders on Hospital Admissions of Children and Adolescents: A Population-Based Study , 2010, Public Health Genomics.

[15]  P. Hammond,et al.  Large‐scale objective phenotyping of 3D facial morphology , 2012, Human mutation.

[16]  Christine M. Cutillo,et al.  Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective , 2017, Clinical and translational science.

[17]  H. Dawkins,et al.  Blueprint for a deliberative public forum on biobanking policy: were theoretical principles achievable in practice? , 2013, Health expectations : an international journal of public participation in health care and health policy.

[18]  F. Bianchi,et al.  Primary Prevention of Congenital Anomalies: Recommendable, Feasible and Achievable , 2015, Public Health Genomics.

[19]  Steven J. M. Jones,et al.  FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project. , 2014, American journal of human genetics.

[20]  Makoto Suematsu,et al.  Japan’s initiative on rare and undiagnosed diseases (IRUD): towards an end to the diagnostic odyssey , 2017, European Journal of Human Genetics.

[21]  C. Tifft,et al.  The NIH Undiagnosed Diseases Program: lessons learned. , 2011, JAMA.

[22]  G. Baynam.  The need for genetic studies of Indigenous Australians , 2012, The Medical journal of Australia.

[23]  Timo Lassmann,et al.  Reference genotype and exome data from an Australian Aboriginal population for health-based research , 2016, Scientific Data.

[24]  S. Mallal,et al.  HLA-B*5701 screening for hypersensitivity to abacavir. , 2008, The New England journal of medicine.

[25]  B. Fernandez,et al.  Utility of whole‐exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care , 2015, Clinical genetics.

[26]  Tudor Groza,et al.  Phenotyping: Targeting genotype's rich cousin for diagnosis , 2014, Journal of paediatrics and child health.

[27]  Eric J Topol,et al.  Individualized Medicine from Prewomb to Tomb , 2014, Cell.

[28]  B. Knoppers,et al.  Current trends in biobanking for rare diseases: a review , 2014 .

[29]  H. Dawkins,et al.  Awakening Australia to Rare Diseases: Symposium report and preliminary outcomes , 2011, Orphanet journal of rare diseases.

[30]  Leslie G Biesecker,et al.  Next‐generation sequencing demands next‐generation phenotyping , 2012, Human mutation.

[31]  F. Alkuraya,et al.  Increasing the sensitivity of clinical exome sequencing through improved filtration strategy , 2016, Genetics in Medicine.

[32]  Peter Szolovits,et al.  Genetic Misdiagnoses and the Potential for Health Disparities. , 2016, The New England journal of medicine.

[33]  Michael Brudno,et al.  PhenomeCentral: A Portal for Phenotypic and Genotypic Matchmaking of Patients with Rare Genetic Diseases , 2015, Human mutation.

[34]  P. Claes,et al.  The Facial Evolution: Looking Backward and Moving Forward , 2013, Human mutation.

[35]  Peter N. Robinson,et al.  The Human Phenotype Ontology: Semantic Unification of Common and Rare Disease , 2015, American journal of human genetics.

[36]  J. Charrow,et al.  Increased Wnt and Notch signaling: a clue to the renal disease in Schimke immuno-osseous dysplasia? , 2016, Orphanet Journal of Rare Diseases.

[37]  A. J. Bass,et al.  A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage system. , 2008, Australian health review : a publication of the Australian Hospital Association.

[38]  J. Goldblatt,et al.  The impact of single gene and chromosomal disorders on hospital admissions in an adult population , 2011, Journal of Community Genetics.

[39]  Magalie S Leduc,et al.  Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.

[40]  François Schiettecatte,et al.  OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders , 2014, Nucleic Acids Res..

[41]  P. Robinson,et al.  RD-Connect: An Integrated Platform Connecting Databases, Registries, Biobanks and Clinical Bioinformatics for Rare Disease Research , 2014, Journal of General Internal Medicine.

[42]  P. Claes,et al.  Objective Monitoring of mTOR Inhibitor Therapy by Three-Dimensional Facial Analysis , 2013, Twin Research and Human Genetics.

[43]  Christine M. Cutillo,et al.  Progress in Rare Diseases Research 2010–2016: An IRDiRC Perspective , 2017, Clinical and translational science.

[44]  M. Khoury,et al.  The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? , 2007, Genetics in Medicine.

[45]  Simon Woods,et al.  International Charter of principles for sharing bio-specimens and data , 2014, European Journal of Human Genetics.

[46]  S. Wilton,et al.  RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes. , 2005, Current gene therapy.

[47]  W. Chung,et al.  Clinical application of whole-exome sequencing across clinical indications , 2015, Genetics in Medicine.

[48]  Michael Brudno,et al.  PhenoTips: Patient Phenotyping Software for Clinical and Research Use , 2013, Human mutation.

[49]  Caron Molster,et al.  Survey of healthcare experiences of Australian adults living with rare diseases , 2016, Orphanet Journal of Rare Diseases.

[50]  In-Hee Lee,et al.  Prioritizing Disease‐Linked Variants, Genes, and Pathways with an Interactive Whole‐Genome Analysis Pipeline , 2014, Human mutation.

[51]  Caron Molster,et al.  Key outcomes from stakeholder workshops at a symposium to inform the development of an Australian national plan for rare diseases , 2012, Orphanet Journal of Rare Diseases.

[52]  Simon Woods,et al.  Rare diseases and now rare data? , 2013, Nature Reviews Genetics.

[53]  Y. Zurynski,et al.  Call for a national plan for rare diseases , 2010, Journal of paediatrics and child health.

[54]  P. Robinson,et al.  The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. , 2008, American journal of human genetics.

[55]  Ó. Zurriaga,et al.  Rare diseases epidemiology research. , 2010, Advances in experimental medicine and biology.

[56]  H. Dawkins,et al.  An Australian Approach to the Policy Translation of Deliberated Citizen Perspectives on Biobanking , 2011, Public Health Genomics.

[57]  K. Boycott,et al.  Rare-disease genetics in the era of next-generation sequencing: discovery to translation , 2013, Nature Reviews Genetics.

[58]  Peter N. Robinson,et al.  Deep phenotyping for precision medicine , 2012, Human mutation.

[59]  Tudor Groza,et al.  The Human Phenotype Ontology in 2017 , 2016, Nucleic Acids Res..

[60]  S. Fullerton,et al.  Using Genetic Technologies To Reduce, Rather Than Widen, Health Disparities. , 2016, Health affairs.

[61]  F. Alkuraya,et al.  Revisiting the morbid genome of Mendelian disorders , 2016, Genome Biology.

[62]  W. Gahl.  The Battlefield of Rare Diseases: Where Uncommon Insights Are Common , 2012, Science Translational Medicine.

[63]  Muin J Khoury,et al.  Planning for the Future of Epidemiology in the Era of Big Data and Precision Medicine. , 2015, American journal of epidemiology.

[64]  Christopher P Austin,et al.  ‘IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases , 2016, European Journal of Human Genetics.

[65]  Petra Helmholz,et al.  3-Dimensional Facial Analysis—Facing Precision Public Health , 2017, Front. Public Health.

[66]  Gorazd Rudolf,et al.  Phenotype-driven gene target definition in clinical genome-wide sequencing data interpretation , 2016, Genetics in Medicine.

[67]  F. Stanley,et al.  Trends in neural tube defects in Western Australia in Indigenous and non-Indigenous populations. , 2004, Paediatric and perinatal epidemiology.

[68]  S. Groft,et al.  Rare diseases - avoiding misperceptions and establishing realities: the need for reliable epidemiological data. , 2010, Advances in experimental medicine and biology.

[69]  Daniel R. Masys,et al.  News from the NIH: potential contributions of the behavioral and social sciences to the precision medicine initiative , 2015, Translational behavioral medicine.

[70]  B. Knoppers,et al.  Extending the reach of public health genomics: What should be the agenda for public health in an era of genome-based and “personalized” medicine? , 2010, Genetics in Medicine.

[71]  Simon Woods,et al.  ‘You should at least ask’. The expectations, hopes and fears of rare disease patients on large-scale data and biomaterial sharing for genomics research , 2016, European Journal of Human Genetics.

[72]  Domenica Taruscio,et al.  Undiagnosed Diseases Network International (UDNI): White paper for global actions to meet patient needs. , 2015, Molecular genetics and metabolism.

[73]  Ana Rath,et al.  WHO International Classification of Diseases (ICD) Revision Process: incorporating rare diseases into the classification scheme: state of art , 2010, Orphanet Journal of Rare Diseases.

[74]  Chad A Shaw,et al.  Molecular Diagnostic Experience of Whole-Exome Sequencing in Adult Patients , 2015, Genetics in Medicine.

[75]  R. Valdez,et al.  Public Health and Rare Diseases: Oxymoron No More , 2016, Preventing chronic disease.

[76]  Michael Q. Zhang,et al.  Integrative analysis of 111 reference human epigenomes , 2015, Nature.

[77]  A. Jaffe.  Orphan lung diseases in childhood: still unadopted? , 2005, Thorax.

[78]  Ana Rath,et al.  Rare diseases in ICD11: making rare diseases visible in health information systems through appropriate coding , 2015, Orphanet Journal of Rare Diseases.

[79]  K. Flanigan,et al.  Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene , 2014, Molecular therapy. Nucleic acids.